PER 2.35% 8.7¢ percheron therapeutics limited

plenty of news coming soon

  1. 5,055 Posts.
    lightbulb Created with Sketch. 274
    Following the manufacture of sufficient supplies of the drug compound by ANP?s technology partner, Isis Pharmaceuticals Inc., ANP has now commenced formulation of this raw material into injectible product to be used in the clinical trial. This drug product formulation work should be completed in April 2011.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.002(2.35%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.